1. Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations
   Katherine E. Pendleton et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
2. Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation
   David T. Coleman et al, 2009, Molecular Cancer Therapeutics CrossRef
3. Cancer Metabolism: Current Understanding and Therapies
   Jessica L. Counihan et al, 2018, Chemical Reviews CrossRef
4. Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
   Sundary Sormendi et al, 2018, Frontiers in Immunology CrossRef
5. Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs
   Manuel Gámez-Chiachio et al, 2022, Cancers CrossRef
6. Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways
   Fahad Khan et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
7. Lipid metabolism and cancer progression: The missing target in metastatic cancer treatment
   Maxwell Omabe et al, 2015, Journal of Applied Biomedicine CrossRef
8. Targeting metabolism in breast cancer: How far we can go?
   Jing-Pei Long, 2016, World Journal of Clinical Oncology CrossRef
9. Metabolic Plasticity in Chemotherapy Resistance
   Maria Andrea Desbats et al, 2020, Frontiers in Oncology CrossRef
10. Relationship between metabolic reprogramming and drug resistance in breast cancer
    Linlin Lv et al, 2022, Frontiers in Oncology CrossRef
11. Lipid metabolism in malignant tumor brain metastasis: reprogramming and therapeutic potential
    Yan-Jie Cheng et al, 2023, Expert Opinion on Therapeutic Targets CrossRef
12. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies
    Dimitri Vanauberg et al, 2023, Oncogenesis CrossRef